Advertisement
Screener

PHATHOM PHARMACEUTICALS, INC. (PHAT) ROI

PHATHOM PHARMACEUTICALS, INC. (PHAT) ROI

  • 2026-06-30: ROI 55.14%.
  • 2026-03-31: ROI 90.78%.
  • 2025-12-31: ROI 96.58%.
  • 2025-09-30: ROI 127.44%.

Complete source-backed roi history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-3055.14%
2026-03-3190.78%
2025-12-3196.58%
2025-09-30127.44%
2025-06-30164.51%
2025-03-31255.89%
2024-12-31640.83%
2024-09-302982.03%
2024-06-30500.14%
2024-03-31-47428.85%
2023-12-31-309.75%
2022-12-31-966.86%
2021-06-30-88.55%
2021-03-31-67.92%
2020-12-31-53.50%
2020-09-30-85.39%
2020-06-30-88.36%

Annual ROI

DateROI
2025-12-3196.58%
2024-12-31640.83%
2023-12-31-309.75%
2022-12-31-966.86%
2020-12-31-53.50%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
Neurogene Inc. (NGNE)$0.625B-4.46